The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

HLA-C  -  major histocompatibility complex, class I, C

Homo sapiens

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of HLA-C

  • The S gene (corneodesmosin), located 160 kb telomeric of HLA-C, is a strong candidate for psoriasis due to its reportedly exclusive expression in differentiating keratinocytes [1].
  • Jeg-3 choriocarcinoma cells constitutively express HLA-G and low levels of a novel HLA-C gene product [2].
  • The defects include a lower expression of all HLA class I antigens compared to EBV transformed normal B-blasts, and selective down-regulation of certain HLA-A and HLA-C alleles [3].
  • HLA-A, HLA-B, HLA-C, and HLA-D typing was performed in 47 mothers of patients suffering from ocular toxoplasmosis to investigate whether an immunogenetic predisposition exists for developing congenital toxoplasmosis in their offspring [4].
  • HLA-B and HLA-C alleles were resolved to four digits by a combination of molecular methods, and their respective associations with outcomes of HIV-1 infection were analyzed by statistical procedures appropriate for continuous or categorical data [5].
  • While the previously reported association between TNF*-238A and psoriasis seems to primarily reflect LD with PSORS1, TNF*-857T may represent a risk factor for PsA that is independent of the PSORS1 allele [6].
 

High impact information on HLA-C

  • Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C [7].
  • Relationship between HLA-C locus and restenosis after coronary artery balloon angioplasty [8].
  • In addition, different arrangements of HLA-C are seen at inhibitory NK immune synapses, and these alter as NK synapses mature, but in a fashion distinct from that seen upon T cell activation [9].
  • After accumulation of target cell human leukocyte antigen (HLA)-C at inhibitory natural killer (NK) cell immune synapses, some HLA-C transfers from target cells to NK cell plasma membranes and cytoplasm [9].
  • This unexpected intercellular transfer of HLA-C is dependent on NK receptor recognition, since HLA-Cw6 or -Cw4 but not -Cw3 transfer to an NK transfectant expressing killer Ig-like receptor (KIR)2DL1 [9].
 

Chemical compound and disease context of HLA-C

  • Alanine at residue 73 (Ala-73) and aspartate at residue 9 (Asp-9) are characteristic to both Cw6 and Cw7 alleles of HLA-C gene and have been suggested as possible markers for psoriasis vulgaris (PsV) [10].
  • It is suggested that alanine at position 73 of HLA-C molecules can be a good marker for psoriasis vulgaris and that this residue may play an important role in determining susceptibility to this disease [11].
 

Biological context of HLA-C

 

Anatomical context of HLA-C

  • These results suggest that HLA-C molecules may deliver negative regulatory signals to some non-MHC-restricted T cells in a manner similar to that described previously for particular NK cells [13].
  • Similar patterns of HLA-C-mediated resistance were also found with two polyclonal T cell lines generated from the peripheral blood lymphocytes of unrelated donors [13].
  • Formation of MHC complexes with particular peptides did not appear to be essential to confer resistance, since a cell line with defective peptide transporter genes (TAP genes), when transfected with an appropriate HLA-C allele, was as resistant to lysis as HLA-C transfectant lines with normal TAP function [13].
  • Alloreactive cytotoxic T lymphocytes (CTL), natural killer (NK) cells, and cellular glycosidases all recognize B*4601 as though it were an HLA-C allotype [16].
  • Eighty-five percent of the chondrocytes had strong representation of Class I molecules, and individual specificities for HLA-A, HLA-B, and HLA-C could be detected [17].
 

Associations of HLA-C with chemical compounds

  • In particular, conserved motifs in the alpha 1 helix and the conserved glycine at the base of the B pocket (position 45) provide a combination of features that is uniquely found in HLA-C molecules [12].
  • Fifty-two patients with PsA and 73 random matched controls from a Jewish population were selected and DNA typed by polymerase chain reaction-single-strand oligonucleotide probe (PCR-SSOP) (HLA-C), PCR sequence-specific primers (PCR-SSP) (HLA-B, -DR), radioactive PCR (MICA-TM polymorphism in the transmembrane region), and PCR-RFLP (TNF) [18].
  • This soluble receptor binds specifically to HLA-C alleles with serine 77 and asparagine 80 in cell adhesion assays [19].
  • Several other class I molecules, notably HLA-C antigens, are reactive in this system, and it may be capable of recognizing subtypes such as A*0207 which also carry free cysteine [20].
  • RESULTS: All patients possessed in their HLA-C antigens an alanine residue at position 73 (p < 0.002) [21].
 

Physical interactions of HLA-C

 

Regulatory relationships of HLA-C

  • For both types of effector cells, direct binding to HLA-C molecules was necessary to achieve inhibition since preincubation with mAb specific for class I molecules destroyed the protection from lysis of HLA-Cw7 expressing target cells. mAbs specific for CD3 and CD8 molecules had no influence on lysis or inhibition of the NK-like T cells [13].
 

Other interactions of HLA-C

  • In comparison with HLA-A and -B, HLA-C alleles are more closely related to each other, there being less variation in residues of the antigen recognition site and more variation at other positions [12].
  • All MM cell lines constitutively expressed class I, but not class II, surface antigen, and all three class I loci (HLA-A, HLA-B, and HLA-C) were expressed [23].
  • The possible role of carbohydrate in the interaction of HLA-C with a human inhibitory natural Killer cell Immunoglobulin-like Receptor with two Ig domains, KIR2DL1, was investigated [24].
  • Our present data indicate that a single amino acid difference greatly influences the p58.1/p50.1 affinity for their HLA-C ligand and suggests a possible role of position 70 as a contact site in the natural killer cell receptor/major histocompatibility complex class I interaction [25].
  • Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin [26].
 

Analytical, diagnostic and therapeutic context of HLA-C

  • For bone marrow transplantation the HLA-C and -DQ alleles are also considered [27].
  • Molecular cloning of HLA-C- and HLA-B-specific receptors has revealed new members of the immunoglobulin superfamily with two or three Ig-like domains, respectively, in their extracellular portion [28].
  • The data thus indicate that HLA-C-restricted CTLs may have an under-appreciated antiviral role in the setting of Nef in vivo and suggest a benefit of promoting HLA-C-restricted CTLs for immunotherapy or vaccine development [29].
  • The frequency distribution of the 14-HLA-A, 18 HLA-B, 5 HLA-C and 10 HLA-D antigens, which were tested, was similar in patients with obstructive, provocable obstructive or non-obstructive HCM to that of a control group of 800 normal persons [30].
  • At present, the possible involvement of HLA-C antigen in liver transplantation is still unexplored [31].

References

  1. S gene (Corneodesmosin) diversity and its relationship to psoriasis; high content of cSNP in the HLA-linked S gene. Enerbäck, C., Enlund, F., Inerot, A., Samuelsson, L., Wahlström, J., Swanbeck, G., Martinsson, T. J. Invest. Dermatol. (2000) [Pubmed]
  2. The role of MHC class I expression in developmental tumours. Stern, P.L., Rinke de Wit, T.F. Semin. Cancer Biol. (1991) [Pubmed]
  3. Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines. Masucci, M.G., Klein, E. Semin. Cancer Biol. (1991) [Pubmed]
  4. HLA typing in congenital toxoplasmosis. Meenken, C., Rothova, A., de Waal, L.P., van der Horst, A.R., Mesman, B.J., Kijlstra, A. The British journal of ophthalmology. (1995) [Pubmed]
  5. Human leukocyte antigen B58 supertype and human immunodeficiency virus type 1 infection in native Africans. Lazaryan, A., Lobashevsky, E., Mulenga, J., Karita, E., Allen, S., Tang, J., Kaslow, R.A. J. Virol. (2006) [Pubmed]
  6. TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele. Reich, K., Hüffmeier, U., König, I.R., Lascorz, J., Lohmann, J., Wendler, J., Traupe, H., Mössner, R., Reis, A., Burkhardt, H. Arthritis Rheum. (2007) [Pubmed]
  7. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Colonna, M., Brooks, E.G., Falco, M., Ferrara, G.B., Strominger, J.L. Science (1993) [Pubmed]
  8. Relationship between HLA-C locus and restenosis after coronary artery balloon angioplasty. Watanabe, Y., Yamada, N., Yokoi, H., Fujiwara, Y., Mokuno, H., Daida, H., Yamaguchi, H. JAMA (1997) [Pubmed]
  9. Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses. Carlin, L.M., Eleme, K., McCann, F.E., Davis, D.M. J. Exp. Med. (2001) [Pubmed]
  10. Study of alanine-73 and aspartate-9 of HLA-C locus in Saudi psoriasis patients, using sequence-specific primers (PCR-SSP). Abanmi, A., Al Harthi, F., Al Agla, R., Khan, H.A., Tariq, M. J. Biochem. Mol. Biol. (2005) [Pubmed]
  11. Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris. Asahina, A., Akazaki, S., Nakagawa, H., Kuwata, S., Tokunaga, K., Ishibashi, Y., Juji, T. J. Invest. Dermatol. (1991) [Pubmed]
  12. Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. Zemmour, J., Parham, P. J. Exp. Med. (1992) [Pubmed]
  13. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells. Falk, C.S., Steinle, A., Schendel, D.J. J. Exp. Med. (1995) [Pubmed]
  14. Isolation and characterization of yeast artificial chromosome clones linking the HLA-B and HLA-C loci. Bronson, S.K., Pei, J., Taillon-Miller, P., Chorney, M.J., Geraghty, D.E., Chaplin, D.D. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  15. CpG islands and HTF islands in the HLA class I region: investigation of the methylation status of class I genes leads to precise physical mapping of the HLA-B and -C genes. Pontarotti, P., Chimini, G., Nguyen, C., Boretto, J., Jordan, B.R. Nucleic Acids Res. (1988) [Pubmed]
  16. The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C. Barber, L.D., Percival, L., Valiante, N.M., Chen, L., Lee, C., Gumperz, J.E., Phillips, J.H., Lanier, L.L., Bigge, J.C., Parekh, R.B., Parham, P. J. Exp. Med. (1996) [Pubmed]
  17. The expression of major histocompatibility antigens on human articular chondrocytes. Lance, E.M., Kimura, L.H., Manibog, C.N. Clin. Orthop. Relat. Res. (1993) [Pubmed]
  18. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. González, S., Brautbar, C., Martínez-Borra, J., López-Vazquez, A., Segal, R., Blanco-Gelaz, M.A., Enk, C.D., Safriman, C., López-Larrea, C. Hum. Immunol. (2001) [Pubmed]
  19. Human natural killer cell inhibitory receptors bind to HLA class I molecules. Döhring, C., Colonna, M. Eur. J. Immunol. (1996) [Pubmed]
  20. Chemical reactivity of an HLA-B27 thiol group. Whelan, M.A., Archer, J.R. Eur. J. Immunol. (1993) [Pubmed]
  21. Do specific pockets of HLA-C molecules predispose Jewish patients to psoriasis vulgaris? Roitberg-Tambur, A., Friedmann, A., Tzfoni, E.E., Battat, S., Ben Hammo, R., Safirman, C., Tokunaga, K., Asahina, A., Brautbar, C. J. Am. Acad. Dermatol. (1994) [Pubmed]
  22. Definition of polymorphic residues on killer Ig-like receptor proteins which contribute to the HLA-C binding site. Richardson, J., Reyburn, H.T., Luque, I., Valés-Gómez, M., Strominger, J.L. Eur. J. Immunol. (2000) [Pubmed]
  23. HLA antigen expression and malignant mesothelioma. Christmas, T.I., Manning, L.S., Davis, M.R., Robinson, B.W., Garlepp, M.J. Am. J. Respir. Cell Mol. Biol. (1991) [Pubmed]
  24. N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors. Baba, E., Erskine, R., Boyson, J.E., Cohen, G.B., Davis, D.M., Malik, P., Mandelboim, O., Reyburn, H.T., Strominger, J.L. Hum. Immunol. (2000) [Pubmed]
  25. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Biassoni, R., Pessino, A., Malaspina, A., Cantoni, C., Bottino, C., Sivori, S., Moretta, L., Moretta, A. Eur. J. Immunol. (1997) [Pubmed]
  26. Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin. Setini, A., Beretta, A., De Santis, C., Meneveri, R., Martayan, A., Mazzilli, M.C., Appella, E., Siccardi, A.G., Natali, P.G., Giacomini, P. Hum. Immunol. (1996) [Pubmed]
  27. Pyrosequencing(R)-based strategies for improved allele typing of human leukocyte antigen Loci. Ringquist, S., Styche, A., Rudert, W.A., Trucco, M. Methods Mol. Biol. (2006) [Pubmed]
  28. Receptors for HLA class-I molecules in human natural killer cells. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M.C., Moretta, L. Annu. Rev. Immunol. (1996) [Pubmed]
  29. Nef interference with HIV-1-specific CTL antiviral activity is epitope specific. Adnan, S., Balamurugan, A., Trocha, A., Bennett, M.S., Ng, H.L., Ali, A., Brander, C., Yang, O.O. Blood (2006) [Pubmed]
  30. HLA complex and hypertrophic cardiomyopathy in a European population. Beckers, J., Vandeputte, R., Geboers, J., DeGeest, H. Eur. Heart J. (1985) [Pubmed]
  31. Human leukocyte antigen-C in short- and long-term liver graft acceptance. Moya-Quiles, M.R., Muro, M., Torío, A., Sánchez-Bueno, F., Miras, M., Marín, L., García-Alonso, A.M., Parrilla, P., Dausset, J., Alvarez-López, M.R. Liver Transpl. (2003) [Pubmed]
 
WikiGenes - Universities